Ari Benjamin Cuperfain

Ari Benjamin Cuperfain

Auto-generated profile, based on publicly available information

Ari Benjamin Cuperfain

University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2021 in BJPsych Open
Verified
Journal Article
Open access
PDF file
ACAri B. Cuperfain
Ari B. Cuperfain
KHKatrina Hui
Katrina Hui
SBSuze G. Berkhout
Suze G. Berkhout
GFGeorge Foussias
George Foussias
DGDavid Gratzer
David Gratzer
JZJuveria Zaheer
Juveria Zaheer
Background: Measurement-based care (MBC) in mental health improves patient outcomes and is a component of many national guidelines for mental healthcare delivery. Nevertheless, MBC is not routinely integrated into clinical practice. Several known reasons for the lack of integration exist but one lesser explored variable is the subjective perspectives of providers and patients about MBC. Such perspectives are critical to understand facilitators and barriers to improve the integration of MBC into routine clinical practice. Aims: This study aimed to uncover the perspectives of various stakeholders towards MBC within a single treatment centre. Method: Researchers conducted qualitative semi-structured interviews with patients (n = 15), family members (n = 7), case managers (n = 8) and psychiatrists (n = 6) engaged in an early-psychosis intervention programme. Data were analysed using thematic analysis, informed by critical realist theory. Results: Analysis converged on several themes. These include (a) implicit negative assumptions; (b) relevance and utility to practice; (c) equity versus flexibility; and (d) shared decision-making. Providers assumed patients’ perspectives of MBC were negative. Patients’ perspectives of MBC were actually favourable, particularly if MBC was used as an instrument to engage patients in shared decision-making and communication rather than as a dogmatic and rigid clinical decision tool. Conclusions: This qualitative study presents the views of various stakeholders towards MBC, providing an in-depth examination of the barriers and facilitators to MBC through qualitative investigation. The findings from this study should be used to address the challenges organisations have experienced in implementing MBC.

1 April 2020 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
ACAri B. Cuperfain
Ari B. Cuperfain
JKJames L. Kennedy
James L. Kennedy
VGVanessa F. Gonçalves
Vanessa F. Gonçalves

2 March 2021 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
JTJessie Jia Tao
Jessie Jia Tao
AAArnav Agarwal
Arnav Agarwal
ACAri Benjamin Cuperfain
Ari Benjamin Cuperfain
CPChristian Pagnoux
Christian Pagnoux
Granulomatosis with polyangiitis (GPA) is a rare necrotising small vessel vasculitis typically associated with oronasal, pulmonary and renal manifestations. Pancreatic disease is an exceedingly rare initial presentation and is associated with delayed diagnosis and rapid progression. We discuss a 66-year-old woman presenting with epigastric pain, elevated lipase and radiographic evidence of focal pancreatitis. She had no relevant medical history and no lithiasis seen on imaging. Pertinent findings include strawberry gingivitis, positive proteinase-antineutrophil cytoplasm antibody (98% specificity) and focal nodular parenchymal lung lesions on CT chest—all of which are consistent with a diagnosis of GPA. She was promptly started on high-dose steroids which resulted in significant clinical and biochemical improvement. Cyclophosphamide was added once biopsy confirmed the absence of malignancy. In order to optimise the clinical outcomes of GPA, physicians must keep a wide differential and high index of suspicion in the setting of unexplained pancreatitis with systemic features.

8 February 2023 in Journal of Substance Use
Verified
Journal Article
Closed access
ACAri B. Cuperfain
Ari B. Cuperfain
GKGali Katznelson
Gali Katznelson
TCTianna Costa
Tianna Costa
PWPatrick Wong
Patrick Wong
NBNarges Beyraghi
Narges Beyraghi
NCNitin Chopra
Nitin Chopra
Opioid agonist therapy is first line in the management of opioid use disorder (OUD). Many guidelines support buprenorphine as the optimal treatment due to its preferred safety profile. Extended-rel...

1 June 2023 in Canadian Journal of Addiction
Verified
Journal Article
Closed access
NBNarges Md Beyraghi
Narges Md Beyraghi
ACAri B. Md Cuperfain
Ari B. Md Cuperfain
YGYasaman Ghazavi
Yasaman Ghazavi
PKPamela MD Kaduri
Pamela MD Kaduri
SLSara RN Ling
Sara RN Ling
Objectives: This paper describes an interdisciplinary outpatient service developed during the COVID-19 pandemic to support and ensure continuity of care for patients with substance use and concurrent mental health disorders. Methods: This service provides 2 weeks of intensive mental health and addiction support to patients recently discharged from the hospital. Here we describe the formation of the service, data on service utilization, and initial qualitative evaluation of the patient experience with this service. Results: Patients accessing this service had high rates of treatment engagement, with an average of 5.6 visits per patient, and were most commonly receiving treatment for alcohol (68.0%), stimulant (47.7%), and opioid (37.3%) use disorders. Patients reported positive experiences with the service, valuing the high frequency and low-barrier contact. Conclusions: Interdisciplinary teams providing brief and intensive interdisciplinary support to patients with substance use disorders after inpatient hospitalizations are feasible and well-received by patients. Objectifs: Cet article décrit un service ambulatoire interdisciplinaire mis en place pendant la pandémie de COVID-19 pour soutenir et assurer la continuité des soins pour les patients souffrant de toxicomanie et de troubles mentaux concomitants. Méthodes: Ce service offre deux semaines de soutien intensif en matière de santé mentale et d’addiction à des patients récemment sortis de hôpital. Nous décrivons ici la création du service, des données sur l’utilisation du service et l'évaluation qualitative initiale de l’expérience des patients avec ce service. Résultats: Les patients qui accèdent à ce service ont des taux élevés d’engagement dans le traitement, avec une moyenne de 5,6 visites par patient et reçoivent le plus souvent un traitement pour un trouble lié à l’usage d’alcool (68,0%), de stimulants (47,7%) et d’opioïdes (37,3%). Les patients ont fait part d’expériences positives avec le service, appréciant la fréquence élevée et les contacts à faibles barrières. Conclusions: Les équipes interdisciplinaires fournissant un soutien interdisciplinaire bref et intensif aux patients souffrant de troubles liés à l’utilisation de substances psychoactives après une hospitalisation sont réalisables et bien accueillies par les patients.

1 January 2019 in European Neuropsychopharmacology
Verified
Journal Article
Open access
VGVanessa F. Gonçalves
Vanessa F. Gonçalves
CCCarolina Cappi
Carolina Cappi
CHChristian M. Hagen
Christian M. Hagen
ADAndriy Derkach
Andriy Derkach
CZClement C Zai
Clement C Zai
LSLei Sun
Lei Sun